Top

Published in:

01-12-2013 | Brief Report

Impact of Oral Antipsychotic Medication Adherence on Healthcare Resource Utilization Among Schizophrenia Patients with Medicare Coverage

Authors: Steve Offord, Jay Lin, Bruce Wong, Dario Mirski, Ross A. Baker

Published in: Community Mental Health Journal | Issue 6/2013

Abstract

Nonadherence to antipsychotic medications is widespread and compromises the outcome of patients with schizophrenia. Using the MarketScan Medicare claims database, this study examined the impact of medication adherence on healthcare utilization among Medicare insured schizophrenia patients. The study population was separated into two cohorts defined by medication adherence, one with a medication possession ratio (MPR) ≥0.7 (high adherence) and the other with a MPR <0.7(low adherence). Of the 354 patients identified, 126 (36 %) had high adherence (mean ± SD MPR 0.94 ± 0.09) and 228 (64 %) had low adherence (MPR 0.24 ± 0.19). All cause hospitalizations (0.68 vs. 0.44; p = 0.015) and length of stay (LOS) (7.0 vs. 2.6 days; p = 0.005), and relapse hospitalizations (0.22 vs. 0.11; p = 0.028) and LOS (3.2 vs. 0.7 days; p = 0.027) were greater among patients with low adherence. Low adherent Medicare insured patients with schizophrenia require significantly more inpatient care and represent a patient population in which effective interventions are needed to improve disease management.

Ascher-Svanum, H., Zhu, B., Faries, D. E., Salkever, D., Slade, E. P., Peng, X., et al. (2010). The cost of relapse and the predictors of relapse in the treatment of schizophrenia. BMC Psychiatry, 10, 2. doi:10.1186/1471-244X-10-2.PubMedCrossRef

Carlborg, A., Winnerbäck, K., Jönsson, E. G., Jokinen, J., & Nordström, P. (2010). Suicide in schizophrenia. Expert Review of Neurotherapeutics, 10(7), 1153–1164.PubMedCrossRef

Fors, B. M., Isacson, D., Bingefors, K., & Widerlöv, B. (2007). Mortality among persons with schizophrenia in Sweden: An epidemiological study. Nordic Journal of Psychiatry, 61(4), 252–259.PubMedCrossRef

Horvitz-Lennon, M., Donohue, J. M., Domino, M. E., & Normand, S.-L. T. (2009). Improving quality and diffusing best practices: The case of schizophrenia. Health Affairs, 28(3), 701–712.PubMedCrossRef

Howard, R., Rabins, P. V., Seeman, M. V., & Jeste, D. V. (2000). Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: An international consensus. The International Late-Onset Schizophrenia Group. The American Journal of Psychiatry, 157(2), 172–178.PubMedCrossRef

Kane, J. M. (2007). Treatment adherence and long-term outcomes. CNS Spectrums, 12(10 Suppl 17), 21–26.PubMed

Kelin, K., Lambert, T., Brnabic, A. J., Newton, R., Ye, W., Escamilla, R. I., et al. (2011). Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence. Patient Preference and Adherence, 5, 213–222.PubMedCrossRef

Khaykin, E., Eaton, W. W., Ford, D. E., Anthony, C. B., & Daumit, G. L. (2010). Health insurance coverage among persons with schizophrenia in the United States. Psychiatric Services, 61(8), 830–834.PubMedCrossRef

Kirkpatrick, B., Messias, E., Harvey, P. D., Fernandez-Egea, E., & Bowie, C. R. (2008). Is schizophrenia a syndrome of accelerated aging? Schizophrenia Bulletin, 34(6), 1024–1032.PubMedCrossRef

Lindenmayer, J.-P., Liu-Seifert, H., Kulkarni, P. M., Kinon, B. J., Stauffer, V., Edwards, S. E., et al. (2009). Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response. The Journal of Clinical Psychiatry, 70(7), 990–996.PubMedCrossRef

Llorca, P.-M. (2008). Partial compliance in schizophrenia and the impact on patient outcomes. Psychiatry Research, 161(2), 235–247.PubMedCrossRef

Marcus, S. C., & Olfson, M. (2008). Outpatient antipsychotic treatment and inpatient costs of schizophrenia. Schizophrenia Bulletin, 34(1), 173–180.PubMedCrossRef

McFarland, B. H., & Collins, J. C. (2011). Medicaid cutbacks and state psychiatric hospitalization of patients with schizophrenia. Psychiatric Services, 62(8), 871–877.PubMedCrossRef

Meesters, P. D., de Haan, L., Comijs, H. C., Stek, M. L., Smeets-Janssen, M. M. J., Weeda, M. R., et al. (2012). Schizophrenia spectrum disorders in later life: Prevalence and distribution of age at onset and sex in a dutch catchment area. The American Journal of Geriatric Psychiatry, 20(1), 18–28.PubMedCrossRef

Stephenson, J. J., Tuncelli, O., Gu, T., Eisenberg, D., Panish, J., Crivera, C., et al. (2012). Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians’ perceptions of adherence vs. pharmacy claims. International Journal of Clinical Practice, 66(6), 565–573.PubMedCrossRef

US Census Bureau. (2011). US census bureau newsroom: 2010 Census: 2010 census shows 65 and older population growing faster than total U.S. population. Retrieved from http://www.census.gov/newsroom/releases/archives/2010_census/cb11-cn192.html.

Valenstein, M., Copeland, L. A., Owen, R., Blow, F. C., & Visnic, S. (2001). Adherence assessments and the use of depot antipsychotics in patients with schizophrenia. The Journal of Clinical Psychiatry, 62(7), 545–551.PubMedCrossRef

Weiden, P. J., & Olfson, M. (1995). Cost of relapse in schizophrenia. Schizophrenia Bulletin, 21(3), 419–429.PubMedCrossRef

West, J. C., Wilk, J. E., Olfson, M., Rae, D. S., Marcus, S., Narrow, W. E., et al. (2005). Patterns and quality of treatment for patients with schizophrenia in routine psychiatric practice. Psychiatric Services, 56(3), 283–291.PubMedCrossRef

Wu, E. Q., Birnbaum, H. G., Shi, L., Ball, D. E., Kessler, R. C., Moulis, M., et al. (2005). The economic burden of schizophrenia in the United States in 2002. The Journal of Clinical Psychiatry, 66(9), 1122–1129.PubMedCrossRef

Title: Impact of Oral Antipsychotic Medication Adherence on Healthcare Resource Utilization Among Schizophrenia Patients with Medicare Coverage
Authors: Steve Offord
Jay Lin
Bruce Wong
Dario Mirski
Ross A. Baker
Publication date: 01-12-2013
Publisher: Springer US
Published in: Community Mental Health Journal / Issue 6/2013
Print ISSN: 0010-3853
Electronic ISSN: 1573-2789
DOI: https://doi.org/10.1007/s10597-013-9638-y

At a glance: The STEP trials

Springer Medicine

Impact of Oral Antipsychotic Medication Adherence on Healthcare Resource Utilization Among Schizophrenia Patients with Medicare Coverage

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2013

Working With the ‘Difficult’ Patient: The Use of a Contextual Cognitive-Analytic Therapy Based Training in Improving Team Function in a Routine Psychiatry Service Setting

“It’s Us That Have to Deal with it Seven Days a Week”: Carers and Borderline Personality Disorder

Substance Abuse and Smoking Among a Canadian Cohort of First Episode Psychosis Patients

Evaluation of the Psychoeducation Given to the Elderly at Nursing Homes for a Healthy Lifestyle and Developing Life Satisfaction

Readiness for Employment: Perceptions of Mental Health Service Users

Failure and Delay in Treatment-Seeking Across Anxiety Disorders